NVST
$26.05
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
Recent News
1 Healthcare Stock with Exciting Potential and 2 We Ignore
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 3.6% over the past six months, topping the S&P 500 by 2.3 percentage points.
Best Value Stocks to Buy for March 16th
OPRX, NVST and STRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 16, 2026.
All You Need to Know About Envista (NVST) Rating Upgrade to Strong Buy
Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Value Stocks to Buy for March 12th
EAT, PAHC and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 12th, 2026.
Here's Why Envista (NVST) Is a Great 'Buy the Bottom' Stock Now
Envista (NVST) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.